207 related articles for article (PubMed ID: 157798)
21. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy.
Rougier P; Ducreux M; Pignon JP; Elias D; Tigaud JM; Lumbroso J; Ruffie P; Lasser PH
Eur J Cancer; 1991; 27(10):1226-30. PubMed ID: 1835591
[TBL] [Abstract][Full Text] [Related]
22. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
23. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
[TBL] [Abstract][Full Text] [Related]
24. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein.
Daly JM; Kemeny N; Sigurdson E; Oderman P; Thom A
Arch Surg; 1987 Nov; 122(11):1273-7. PubMed ID: 2960296
[TBL] [Abstract][Full Text] [Related]
25. [Case report of a liver metastasis from rectal cancer achieving complete response (CR) by a combination of intra-hepatic arterial infusion of irinotecan (CPT-11) with degradable starch microspheres (DSM) and weekly high-dose intra-hepatic arterial chemotherapy with 5-FU].
Watanabe M; Tsuchiya M; Takita W; Otsuka Y; Tamura A; Yamazaki K; Koshino H; Kurihara A; Kaneko H; Teramoto T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1485-8. PubMed ID: 17033243
[TBL] [Abstract][Full Text] [Related]
26. Regional chemotherapy of colorectal cancer metastatic to the liver.
Niederhuber JE; Ensminger W; Gyves J; Thrall J; Walker S; Cozzi E
Cancer; 1984 Mar; 53(6):1336-43. PubMed ID: 6229326
[TBL] [Abstract][Full Text] [Related]
27. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.
Stagg RJ; Lewis BJ; Friedman MA; Ignoffo RJ; Hohn DC
Ann Intern Med; 1984 May; 100(5):736-43. PubMed ID: 6231876
[TBL] [Abstract][Full Text] [Related]
28. Complications of hepatic artery infusion: a review of 4580 reported cases.
Barnett KT; Malafa MP
Int J Gastrointest Cancer; 2001; 30(3):147-60. PubMed ID: 12540027
[TBL] [Abstract][Full Text] [Related]
29. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.
Martin JK; O'Connell MJ; Wieand HS; Fitzgibbons RJ; Mailliard JA; Rubin J; Nagorney DM; Tschetter LK; Krook JE
Arch Surg; 1990 Aug; 125(8):1022-7. PubMed ID: 2143063
[TBL] [Abstract][Full Text] [Related]
30. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Cohen AM; Schaeffer N; Higgins J
Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
[TBL] [Abstract][Full Text] [Related]
31. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol.
Reed ML; Vaitkevicius VK; Al-Sarraf M; Vaughn CB; Singhakowinta A; Sexon-Porte M; Izbicki R; Baker L; Straatsma GW
Cancer; 1981 Jan; 47(2):402-9. PubMed ID: 6257376
[TBL] [Abstract][Full Text] [Related]
32. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
33. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.
Balch CM; Urist MM; Soong SJ; McGregor M
Ann Surg; 1983 Nov; 198(5):567-73. PubMed ID: 6227295
[TBL] [Abstract][Full Text] [Related]
34. [A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective].
Ishikawa T; Nakamura M; Ohkuma K; Hisano C; Nakano S; Maruyama T; Kaji Y; Niho Y; Masumoto N
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1443-7. PubMed ID: 10969604
[TBL] [Abstract][Full Text] [Related]
35. [Intra-arterial chemotherapy using an implantable infusion pump in liver metastases of colorectal tumors and hepatomas].
Balch CM; Urist MM
Chirurg; 1984 Aug; 55(8):485-93. PubMed ID: 6092009
[No Abstract] [Full Text] [Related]
36. Intraarterial hepatic infusion chemotherapy in metastatic liver cancer.
Oberfield RA
Semin Oncol; 1983 Jun; 10(2):206-14. PubMed ID: 6223373
[No Abstract] [Full Text] [Related]
37. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
38. Preliminary results of a randomized study of intrahepatic infusion versus systemic infusion of 5-fluoro-2'-deoxyuridine for metastatic colorectal carcinoma.
Kemeny N; Daly J
Recent Results Cancer Res; 1986; 100():171-8. PubMed ID: 2942993
[No Abstract] [Full Text] [Related]
39. [A case report of complete remission of liver metastases from colorectal cancer treated with continuous hepatic arterial infusion].
Tokunaga T; Sumimura J; Yoshidome K; Fujita S; Tsuji K; Oota F; Tsuboyama N; Nagai I
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1009-11. PubMed ID: 12894720
[TBL] [Abstract][Full Text] [Related]
40. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
